(S)-(+)-Ibuprofen structure
|
Common Name | (S)-(+)-Ibuprofen | ||
---|---|---|---|---|
CAS Number | 51146-56-6 | Molecular Weight | 206.281 | |
Density | 1.0±0.1 g/cm3 | Boiling Point | 319.6±11.0 °C at 760 mmHg | |
Molecular Formula | C13H18O2 | Melting Point | 49-53ºC | |
MSDS | Chinese USA | Flash Point | 216.7±14.4 °C |
Use of (S)-(+)-Ibuprofen(S)-(+)-Ibuprofen is the S-enantiomer of Ibuprofen. Ibuprofen is an anti-inflammatory inhibitor targeting COX-1 and COX-2 with IC50 of 13 μM and 370 μM, respectively. |
Name | dexibuprofen |
---|---|
Synonym | More Synonyms |
Description | (S)-(+)-Ibuprofen is the S-enantiomer of Ibuprofen. Ibuprofen is an anti-inflammatory inhibitor targeting COX-1 and COX-2 with IC50 of 13 μM and 370 μM, respectively. |
---|---|
Related Catalog |
Density | 1.0±0.1 g/cm3 |
---|---|
Boiling Point | 319.6±11.0 °C at 760 mmHg |
Melting Point | 49-53ºC |
Molecular Formula | C13H18O2 |
Molecular Weight | 206.281 |
Flash Point | 216.7±14.4 °C |
Exact Mass | 206.130676 |
PSA | 37.30000 |
LogP | 3.72 |
Vapour Pressure | 0.0±0.7 mmHg at 25°C |
Index of Refraction | 1.519 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Hazard Codes | Xn:Harmful; |
Risk Phrases | R22;R63 |
Safety Phrases | S36/37-S45 |
RIDADR | 2811.0 |
WGK Germany | 3 |
Hazard Class | 6.1 |
HS Code | 2916399090 |
Precursor 9 | |
---|---|
DownStream 3 | |
HS Code | 2916399090 |
---|---|
Summary | 2916399090 other aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Nat. Chem. Biol. 3(5) , 268-273, (2007) The identification of self-renewing and multipotent neural stem cells (NSCs) in the mammalian brain holds promise for the treatment of neurological diseases and has yielded new insight into brain canc... |
|
The advantages and limitations of the analgesics available for control of postoperative pain after a dental procedure.
SAAD Dig. 29 , 70-81, (2013)
|
|
Pegylation improves the pharmacokinetics and bioavailability of small-molecule drugs hydrolyzable by esterases: a study of phospho-Ibuprofen.
J. Pharmacol. Exp. Ther. 351(1) , 61-6, (2014) Esterase hydrolysis of drugs can accelerate their elimination, thereby limiting their efficacy. Polyethylene glycol (PEG) covalently attached to drugs (pegylation) is known to improve the efficiency o... |
(2S)-2-(4-Isobutylphenyl)propanoic acid |
(S)-(+)-4-Isobutyl-α-methylphenylacetic Acid |
(S)-2-(4-Isobutylphenyl)propanoic acid |
Benzeneacetic acid, α-methyl-4-(2-methylpropyl)-, (αS)- |
(+)-(S)-Ibuprofen |
(+)-ibuprofen |
MFCD00069289 |
Dexibuprofen |
(S)-4-Isobutyl-α-methylphenylacetic acid |
(2S)-2-[4-(2-methylpropyl)phenyl]propanoic acid |
(S)-(+)-Ibuprofen |
(S)-(+)-2-(4-isobutylphenyl)propanoic acid |
d-Ibuprofen |
(S)-(+)-4-Isobutyl-Alpha-Methylphenylacetic Acid |
Ibuprofen |
(S)-(+)-2-(4-Isobutylphenyl)propionic Acid |
(S)-a-Methyl-4-(2-methylpropyl)benzeneacetic acid |
(S)-ibuprofen |
(2S)-2-[4-(2-Methylpropyl)phenyl]propionic acid |